Cargando…
Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer’s pathology in 5×FAD mice
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder with multifactorial etiology. The role of microglia in the pathogenesis of AD has been increasingly recognized in recent years; however, the detailed mechanisms shaping microglial phenotypes in AD-relevant pathological settings remain...
Autores principales: | Xue, Feng, Tian, Jing, Yu, Chunxiao, Du, Heng, Guo, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956132/ https://www.ncbi.nlm.nih.gov/pubmed/33540048 http://dx.doi.org/10.1016/j.nbd.2021.105272 |
Ejemplares similares
-
Synthetic PPAR Agonist DTMB Alleviates Alzheimer’s Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
por: Oh, Eunji, et al.
Publicado: (2022) -
Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
por: Shen, Guofang, et al.
Publicado: (2020) -
Immortalization of MEF is characterized by the deregulation of specific miRNAs with potential tumor suppressor activity
por: Rizzo, Milena, et al.
Publicado: (2011) -
Microglial immunophenotype in dementia with Alzheimer’s pathology
por: Minett, Thais, et al.
Publicado: (2016) -
Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner
por: Deczkowska, Aleksandra, et al.
Publicado: (2017)